About
Featured Companies
Articles
News
Contact
Sponsors
Featured Companies
Subscribe to Excellence
Welcome aboard! Your submission has been received and you are now a member of the MedicalGold.ca community.
Oops! Something went wrong while submitting the form. Please check the format of your entry.
Biovaxys
Featured Articles
Biovaxys
All Companies Posts
Numinus
Cybin Inc.
Algernon Pharmaceuticals
TRYP Therapeutics
MindMed
Medicenna Therapeutics
Izotropic
Nov 20, 2022
BioVaxys' Universal COVID Vaccine Marches Ahead
Oct 19, 2022
BioVaxys Initiates Preclinical Dosing of Universal SARS-CoV Vaccine
Aug 26, 2022
Important BioVaxys Update: Interview With Chief Medical Officer Dr. David Berd
Jul 5, 2022
Biotech Sector Forms A Double-Bottom | BioVaxys Shares Spike 60% On Heavy Volume
Jun 20, 2022
An Innovative Solution To An Intractable Problem: Immunotherapy For Ovarian Cancer
Apr 26, 2022
Research on a ‘universal’ sarbecovirus vaccine well underway It’s time our vaccines evolved.
Feb 16, 2022
This Biotech's Experimental COVID Vaccine May Deliver Powerful Protection without mRNA Adverse Reactions
Dec 28, 2021
An Insightful Interview with BioVaxys CEO James Passin
Nov 29, 2021
This Canadian Biotech Could Hold the Key to a Universal Coronavirus Vaccine
Oct 20, 2021
BioVaxys Chart Poised For Rally Following Universal SARS Vaccine Patent Filing
Sep 28, 2021
Exclusive Interview with Ken Kovan (COO) and Dr. David Berd (CMO)
Sep 23, 2021
COVID Vaccine Side-Effects Reduced Through Intelligent Engineering
Sep 9, 2021
BioVaxys' COVID T Cell Diagnostic Shows Positive Human Data. Shares Surge!
Jul 23, 2021
BioVaxys Company Update: Stock Soars Upon Positive FDA Feedback for COVID T Cell Diagnostic Test
Jan 26, 2021
Leveraging the Haptenized Vaccine Platform to Eradicate All SARS-CoV-2 Variants
Nov 4, 2020
Waking a Sleeping Giant... Cancer Beware
Nov 3, 2020
The Next Ten Bagger In Canadian Biotech
